Jaguar Health (JAGX) Other Non-Current Liabilities (2014 - 2026)

Jaguar Health's (JAGX) quarterly Other Non-Current Liabilities came in at $187000.0 in Q1 2026, down 99.49% year-on-year from $37.0 million in Q1 2025, and down 99.41% on a QoQ basis from $31.9 million in Q4 2025.

Jaguar Health (JAGX) Other Non-Current Liabilities (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Other Non-Current Liabilities data on file, last reported at $187000.0 in Q1 2026.

  • On a quarterly basis, Other Non-Current Liabilities fell 99.49% year-over-year to $187000.0 in Q1 2026; TTM through Mar 2026 was $187000.0, a 99.49% decrease from a year earlier, with the FY2025 full-year figure at $31.9 million, down 9.77% from the prior year.
  • Other Non-Current Liabilities for Q1 2026 stood at $187000.0, down from $31.9 million in the prior quarter.
  • Over the last five years, Other Non-Current Liabilities for JAGX reached as high as $37.0 million in Q1 2025 and fell as low as $1000.0 in Q1 2022.
  • Historically, Other Non-Current Liabilities has averaged $24.3 million across 5 years, with a median of $30.9 million in 2023.
  • Across the five-year window, Other Non-Current Liabilities surged 783800.0% in 2022 and slumped 99.49% in 2026, its largest moves.
  • Year by year, Other Non-Current Liabilities stood at $7.8 million in 2022, then soared by 294.73% to $30.9 million in 2023, then advanced by 14.26% to $35.4 million in 2024, then retreated by 9.77% to $31.9 million in 2025, then sank by 99.41% to $187000.0 in 2026.
  • Per Business Quant data, the three most recent Other Non-Current Liabilities figures were $187000.0 in Q1 2026, $31.9 million in Q4 2025, and $30.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Nanobiotix 1,774.59 Bn 1,774.53 Bn -
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn -
3 BeOne Medicines 473.53 Bn 468.74 Bn 1.35 Bn
4 Vertex Pharmaceuticals 123.91 Bn 116.66 Bn 2.59 Bn
5 Regeneron Pharmaceuticals 71.79 Bn 63.04 Bn 3.31 Bn
6 Belite Bio 62.15 Bn 62.15 Bn -
7 Argenx Se 54.75 Bn 49.57 Bn 1.41 Bn
8 Alnylam Pharmaceuticals 38.10 Bn 35.10 Bn 959.66 Mn
9 Revolution Medicines 36.11 Bn 36.11 Bn -
10 Jaguar Health 509,443.80 -9.55 Mn 19.11 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 187,000.00
Dec 31, 2025 31.90 Mn
Sep 30, 2025 30.42 Mn
Jun 30, 2025 28.81 Mn
Mar 31, 2025 37.01 Mn
Dec 31, 2024 35.36 Mn
Sep 30, 2024 32.79 Mn
Mar 31, 2024 31.96 Mn
Dec 31, 2023 30.94 Mn
Dec 31, 2022 7.84 Mn
Mar 31, 2022 1,000.00
Dec 31, 2021 1,000.00
Sep 30, 2021 3,000.00
Jun 30, 2021 7,000.00
Mar 31, 2021 12,000.00
Dec 31, 2020 1,000.00
Sep 30, 2020 126,000.00
Jun 30, 2020 4.09 Mn
Mar 31, 2020 1.25 Mn
Dec 31, 2019 1.50 Mn